CIP
QCOR

Convergence Investment Partners’s QUESTCOR PHARMA INC QCOR Stock Holding History

Convergence Investment Partners’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-28,928
Closed -$1.88M – 464
2014
Q1 		$1.88M Sell
28,928
-17,880
-38% -$1.14M 0.29% 120
2013
Q4 		$2.55M Buy
46,808
+40,146
+603% +$2.37M 0.41% 75
2013
Q3 		$386K Buy
+6,662
New +$396K 0.08% 217

Other funds holding QCOR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Convergence Investment Partners's QCOR Position: Q2 2014 in Review

Convergence Investment Partners sold out of QUESTCOR PHARMA INC (QCOR) in Q2 2014, closing a stake of 28,928 shares — an estimated $1.88M sold.

Convergence Investment Partners first reported a position in QCOR in Q3 2013 and held it in 3 quarters. The position peaked at $2.55M in Q4 2013. 320 funds tracked by Wall St. Rank hold QCOR as of Q2 2014.

  • Convergence Investment Partners reported no remaining QUESTCOR PHARMA INC position as of Q2 2014 after selling out during the quarter.
  • Convergence Investment Partners sold 28,928 QUESTCOR PHARMA INC shares in Q2 2014, an estimated $1.88M.
  • Convergence Investment Partners first reported a position in QUESTCOR PHARMA INC in Q3 2013 and held it in 3 quarters.
  • Convergence Investment Partners's QUESTCOR PHARMA INC position peaked at $2.55M in Q4 2013.
  • 320 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q2 2014.

Based on Convergence Investment Partners's 13F filing for Q2 2014, filed 13 Aug 2014.